Results 111 to 120 of about 10,145 (225)
Background and objectiveLower respiratory tract infection (LRTI) is a leading cause of childhood hospitalization worldwide, with high-flow nasal cannula (HFNC) therapy commonly employed as a non-invasive respiratory support method.
Phanthila Sitthikarnkha +6 more
doaj +1 more source
Feeding infants on high flow nasal cannula oxygen therapy (HFNC): An exploration of speech-language pathologists’ decision-making processes [PDF]
There are currently no clear protocols to inform whether or not to orally feed premature infants receiving high flow nasal cannula oxygen therapy (HFNC). There is also a paucity of literature describing how speech-language pathologists (SLPs) decide when
Murphy, R., Harrison, K., Harding, C.
core
Objective This study aimed to analyze the characteristics of patients who fail high-flow nasal cannula(HFNC) therapy for acute hypoxemic respiratory failure(AHRF) and to identify predictors of treatment failure. Methods This single-center, retrospective,
Mingming Xue +10 more
doaj +1 more source
1182: CPAP VERSUS HFNC: A SURVEY OF PRACTICE FOR BRONCHIOLITIS
Neil Fernandes +2 more
openaire +2 more sources
openaire +1 more source
The Application Progress of HFNC in Respiratory Diseases
openaire +1 more source
The best cut-off values of ROX, HR improvement (delta-HR), and HROX indices predict HFNC weaning success.
Pitchayapa Ruchiwit (17972972) +2 more
core +1 more source
Background High-flow nasal cannula (HFNC) in bronchiolitis is widely used beyond guideline recommendations. This study developed targeted, theory-informed implementation strategies to improve appropriate HFNC use in regional and rural
Stuart Dalziel +9 more
core +1 more source
Clinical Outcomes of High-Flow Nasal Cannula Combined with Standardized Acupoint Application in Acute Exacerbations of COPD: A Retrospective Study. [PDF]
Li B +7 more
europepmc +1 more source
High-flow nasal cannula (HFNC) is becoming the gold standard to treat respiratory distress at any age since it potentially provides several significant clinical advantages.
Francesco Montecchia +3 more
core +1 more source

